Cargando…

Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example

BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Holtman, Gea A, Leeuwen, Yvonne Lisman-van, Kollen, Boudewijn J, Escher, Johanna C, Kindermann, Angelika, Rheenen, Patrick F van, Berger, Marjolein Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222604/
https://www.ncbi.nlm.nih.gov/pubmed/24274463
http://dx.doi.org/10.1186/1471-2296-14-179
_version_ 1782343064746983424
author Holtman, Gea A
Leeuwen, Yvonne Lisman-van
Kollen, Boudewijn J
Escher, Johanna C
Kindermann, Angelika
Rheenen, Patrick F van
Berger, Marjolein Y
author_facet Holtman, Gea A
Leeuwen, Yvonne Lisman-van
Kollen, Boudewijn J
Escher, Johanna C
Kindermann, Angelika
Rheenen, Patrick F van
Berger, Marjolein Y
author_sort Holtman, Gea A
collection PubMed
description BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of our choices, using a quality assessment tool for diagnostic accuracy studies (QUADAS-2). DESIGN: The study investigates the diagnostic value of fecal calprotectin for detecting inflammatory bowel disease in children presenting with chronic gastrointestinal symptoms in primary care. It is a prospective cohort study including two cohorts of children: one cohort will be recruited in primary care and the other in secondary/tertiary care. Test results of fecal calprotectin will be compared to one of the two reference standards for inflammatory bowel disease: endoscopy with histopathological examination of mucosal biopsies or assessment of clinical symptoms at 1-year follow-up. DISCUSSION: According to QUADAS-2 the use of two reference standards and the recruitment of patients in two populations may cause differential verification bias and spectrum bias, respectively. The clinical relevance of this potential bias and methods to adjust for this are presented. This study illustrates the importance of awareness of the different kinds of bias that result from choices in the design phase of a diagnostic study in a low prevalence setting. This approach is exemplary for other diagnostic research in primary care.
format Online
Article
Text
id pubmed-4222604
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42226042014-11-07 Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example Holtman, Gea A Leeuwen, Yvonne Lisman-van Kollen, Boudewijn J Escher, Johanna C Kindermann, Angelika Rheenen, Patrick F van Berger, Marjolein Y BMC Fam Pract Study Protocol BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of our choices, using a quality assessment tool for diagnostic accuracy studies (QUADAS-2). DESIGN: The study investigates the diagnostic value of fecal calprotectin for detecting inflammatory bowel disease in children presenting with chronic gastrointestinal symptoms in primary care. It is a prospective cohort study including two cohorts of children: one cohort will be recruited in primary care and the other in secondary/tertiary care. Test results of fecal calprotectin will be compared to one of the two reference standards for inflammatory bowel disease: endoscopy with histopathological examination of mucosal biopsies or assessment of clinical symptoms at 1-year follow-up. DISCUSSION: According to QUADAS-2 the use of two reference standards and the recruitment of patients in two populations may cause differential verification bias and spectrum bias, respectively. The clinical relevance of this potential bias and methods to adjust for this are presented. This study illustrates the importance of awareness of the different kinds of bias that result from choices in the design phase of a diagnostic study in a low prevalence setting. This approach is exemplary for other diagnostic research in primary care. BioMed Central 2013-11-25 /pmc/articles/PMC4222604/ /pubmed/24274463 http://dx.doi.org/10.1186/1471-2296-14-179 Text en Copyright © 2013 Holtman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Holtman, Gea A
Leeuwen, Yvonne Lisman-van
Kollen, Boudewijn J
Escher, Johanna C
Kindermann, Angelika
Rheenen, Patrick F van
Berger, Marjolein Y
Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title_full Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title_fullStr Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title_full_unstemmed Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title_short Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
title_sort challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222604/
https://www.ncbi.nlm.nih.gov/pubmed/24274463
http://dx.doi.org/10.1186/1471-2296-14-179
work_keys_str_mv AT holtmangeaa challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT leeuwenyvonnelismanvan challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT kollenboudewijnj challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT escherjohannac challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT kindermannangelika challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT rheenenpatrickfvan challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample
AT bergermarjoleiny challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample